.codex-plugin/plugin.json

{
  "apps": "./.app.json",
  "author": {
    "name": "Amass Technologies ApS"
  },
  "description": "Amass connects your assistant to six curated biomedical corpora: BioMedCore (43M+ records: peer-reviewed publications from PubMed/PMC and conference abstracts from society meetings), TrialCore (1.2M+ clinical trials from ClinicalTrials.gov and the WHO ICTRP), DrugCore (22K+ harmonized drugs/molecules covering modality, clinical stage, structure, synonyms, and the gene targets each drug acts on; ChEMBL-linked), RegulatoryCore (7K+ unified FDA + EMA marketing authorizations with source documents such as labels, reviews, SmPCs, and EPARs), GeneCore (43K+ harmonized human genes with a target-intelligence layer covering druggability, DepMap essentiality, ChEMBL target class, clinical-precedent tractability, curated safety liabilities, and gnomAD constraint), and PatentCore (preview, life-science patents with full-text search, CPC/IPC classifications, assignees/inventors, and patent families). Users can search and retrieve full records with filters that beat open-web retrieval, and follow cross-links across corpora back to each underlying source.",
  "interface": {
    "capabilities": [],
    "category": "Education & Research",
    "defaultPrompt": [
      "Map the current landscape for oral GLP-1 agonists in obesity \u2014 what's approved, what's in trials, and who holds patents.",
      "Make the case for and against KRAS G12D as a drug target: biology, what's been tried clinically, and failures.",
      "What happened to semaglutide since first approval \u2014 indication expansions, label changes, safety signals, and literature."
    ],
    "developerName": "Amass Technologies ApS",
    "displayName": "Amass",
    "longDescription": "Amass connects your assistant to six curated biomedical corpora: BioMedCore (43M+ records: peer-reviewed publications from PubMed/PMC and conference abstracts from society meetings), TrialCore (1.2M+ clinical trials from ClinicalTrials.gov and the WHO ICTRP), DrugCore (22K+ harmonized drugs/molecules covering modality, clinical stage, structure, synonyms, and the gene targets each drug acts on; ChEMBL-linked), RegulatoryCore (7K+ unified FDA + EMA marketing authorizations with source documents such as labels, reviews, SmPCs, and EPARs), GeneCore (43K+ harmonized human genes with a target-intelligence layer covering druggability, DepMap essentiality, ChEMBL target class, clinical-precedent tractability, curated safety liabilities, and gnomAD constraint), and PatentCore (preview, life-science patents with full-text search, CPC/IPC classifications, assignees/inventors, and patent families). Users can search and retrieve full records with filters that beat open-web retrieval, and follow cross-links across corpora back to each underlying source.",
    "privacyPolicyURL": "https://amass.tech/legal/privacy-policy",
    "shortDescription": "Life sciences intelligence",
    "supportURL": "https://amass.tech/contact",
    "termsOfServiceURL": "https://amass.tech/legal/terms-of-service",
    "websiteURL": "https://amass.tech"
  },
  "name": "app-69fdb4eb74f08191a3deeac63eb3a0f6",
  "version": "7.0.0"
}